Text Size

Driven by advances in scientific knowledge and falling costs, scientists can target the genetic cause of a disease and repair it at the source, raising the possibility of curative treatments for afflictions like blindness and cancer. Salveen Richter of Goldman Sachs Research explains how gene therapy, gene editing and cell engineering are changing the face of medicine as part of our new series, The Long and Short of It, featuring insights from Goldman Sachs on topics that are on the minds of our clients.

Genomic medicine is going to continue to advance and have a huge presence in the field of therapeutics. But further, there’s the huge societal impact as we look to bringing these curative therapies – or potentially curative therapies – to market.